$ZGNX News Article - Zogenix Announces U.S. FDA Acceptance for Priority Review of Supplemental New Drug Application for FINTEPLA (Fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS) https://marketwirenews.com/news-releases/zoge...89088.html
Zogenix (ZGNX) Stock Research Links
My Twitter: WhyteStocks